Recurrent gene fusions are common in high-grade serous ovarian cancer.

被引：0
|
作者：
Lehtonen, Rainer [1 ]
Carpen, Olli [1 ]
Huhtinen, Kaisa [2 ]
Hynninen, Johanna [2 ]
Kaipio, Katja [2 ]
Lamminen, Tarja [2 ]
Cervera, Alejandra [1 ]
Hietanen, Sakari [2 ]
Grenman, Seija [2 ]
Hautaniemi, Sampsa [1 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Turku, Turku, Finland
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B48
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [31] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
  • [32] Mathematical model quantifies the effect of novel combination therapies in high-grade serous ovarian cancer.
    Hautaniemi, Sampsa
    Kozlowska, Emilia
    Farkkila, Anniina
    Vallius, Tuulia
    Carpen, Olli
    Grenman, Seija
    Lehtonen, Rainer
    Hynninen, Johanna
    Hietanen, Sakari
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 121 - 121
  • [33] Targeting new links in the proteostasis network as novel therapies in high-grade serous ovarian cancer.
    Lighty, Kinzie
    Shin, Yonghyun
    Mesmer, Fahmi
    Nakshatri, Harikrishna
    Iwanicki, Marcin
    Mitra, Sumegha
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 66 - 66
  • [34] Differential protein expression patterns in vaginal swabs of patients with high-grade serous ovarian cancer.
    Llaneza, Danielle C.
    Cornelison, Robert
    Petrova, Yuliya I.
    Dobbin, Zachary C.
    Maxwell, Larry
    Conrads, Thomas P.
    Landen, Charles N.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 90 - 90
  • [35] Genomic and functional analysis of gene amplification in high-grade serous and endometrioid ovarian cancer
    Davis, Sally J.
    Simpson, Kaylene J.
    Campbell, Ian G.
    Gorringe, Kylie L.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [36] Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
    Jai N. Patel
    Ioana Braicu
    Kirsten M. Timms
    Cara Solimeno
    Placede Tshiaba
    Julia Reid
    Jerry S. Lanchbury
    Silvia Darb-Esfahani
    Mahrukh K. Ganapathi
    Jalid Sehouli
    Ram N. Ganapathi
    British Journal of Cancer, 2018, 119 : 1060 - 1066
  • [37] Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
    Patel, Jai N.
    Braicu, Ioana
    Timms, Kirsten M.
    Solimeno, Cara
    Tshiaba, Placede
    Reid, Julia
    Lanchbury, Jerry S.
    Darb-Esfahani, Silvia
    Ganapathi, Mahrukh K.
    Sehouli, Jalid
    Ganapathi, Ram N.
    BRITISH JOURNAL OF CANCER, 2018, 119 (09) : 1060 - 1066
  • [38] Niraparib initial dose and its' management in patients with recurrent high-grade serous ovarian cancer
    Grabowski, J. P.
    Glajzer, J.
    Braicu, E. I.
    Sehouli, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
    Christie, Elizabeth L.
    Pattnaik, Swetansu
    Beach, Jessica
    Copeland, Anthony
    Rashoo, Nineveh
    Fereday, Sian
    Hendley, Joy
    Alsop, Kathryn
    Brady, Samuel L.
    Lamb, Greg
    Pandey, Ahwan
    deFazio, Anna
    Thorne, Heather
    Bild, Andrea
    Bowtell, David D. L.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [40] Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
    Elizabeth L. Christie
    Swetansu Pattnaik
    Jessica Beach
    Anthony Copeland
    Nineveh Rashoo
    Sian Fereday
    Joy Hendley
    Kathryn Alsop
    Samuel L. Brady
    Greg Lamb
    Ahwan Pandey
    Anna deFazio
    Heather Thorne
    Andrea Bild
    David D. L. Bowtell
    Nature Communications, 10
12345